Buonaguro, Franco Maria
Puzanov, Igor
Ascierto, Paolo Antonio
Article History
Received: 2 April 2020
Accepted: 8 April 2020
First Online: 14 April 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: PAA has/had a consultant/advisory role for Bristol Myers-Squibb, Roche-Genentech, Merck Sharp & Dohme, Array, Novartis, Merck Serono, Pierre Fabre, Incyte, NewLink Genetics, Genmab, Medimmune, AstraZeneca, Syndax, SunPharma, Sanofi, Idera, Ultimovacs, Sandoz, Immunocore, 4SC, Alkermes, Italfarmaco, Nektar, Boehringer-Ingelheim. He also received research funds from Bristol Myers-Squibb, Roche-Genentech, Array, and travel support from MSD.IP serves as consultant for AmgenFMB